Concepedia

Oliver Sartor

OS

Statistics

Publications

14

Citations

822

H-Index

12

Active since

1993

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

National Cancer Institute

Institut Gustave Roussy

Essen University Hospital

Dana-Farber Cancer Institute

Oliver Sartor is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, prostate cancer, and prostate cancer hormone therapy.

Publications per year

1993–2025

14

Publications

14

177Lu-PSMA-617 versus a change of androgen receptor pathway inhibitor therapy for taxane-naive patients with progressive metastatic castration-resistant prostate cancer (PSMAfore): a phase 3, randomised, controlled trial

Michael J. Morris, Daniel Castellano, Ken Herrmann et al. · The Lancet · 2024 · 258 citations · Full text

, , +17

Time to prostate‐specific antigen nadir independently predicts overall survival in patients who have metastatic hormone‐sensitive prostate cancer treated with androgen‐deprivation therapy

Toni K. Choueiri, Wanling Xie, Anthony V. D’Amico et al. · Cancer · 2009 · 145 citations · Full text

, , +13

Effect of prednisone on prostate-specific antigen in patients with hormone-refractory prostate cancer

Oliver Sartor, M. Weinberger, Andrea Moore et al. · Urology · 1998 · 94 citations

, , +9

Androgen receptor mediates the expression of UDP‐glucuronosyltransferase 2 B15 and B17 genes

Bo‐Ying Bao, Bin‐Fay Chuang, Qianben Wang et al. · The Prostate · 2008 · 79 citations · Full text

, , +17

Antitumor activity of suramin in hormone-refractory prostate cancer controlling for hydrocortisone treatment and flutamide withdrawal as potentially confounding variables

Nancy A. Dawson, Michael R. Cooper, William D. Figg et al. · Cancer · 1995 · 76 citations · Full text

, , +15

1–5 of 14